Neda Safarzadeh | VP, Head IR, Public Relations and Marketing |
Joseph Payne | President and CEO |
Andy Sassine | CFO |
Pad Chivukula | CSO and COO |
Yasmeen Rahimi | Piper Sandler |
Myles Minter | William Blair |
Evan Wang | Guggenheim Securities |
Pete Stavropoulos | Cantor Fitzgerald |
Yanan Zhu | Wells Fargo |
Carly Kenselaar | Citi |
Thomas Yip | H.C. Wainwright |
Yale Jen | Laidlaw and Company |
Greetings, and welcome to Arcturus Therapeutics Second Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host Neda Safarzadeh, Vice President, Head of Investor Relations, Public Relations, and Marketing.